Copyright: ©Author(s) 2026.
World J Nephrol. Mar 25, 2026; 15(1): 113212
Published online Mar 25, 2026. doi: 10.5527/wjn.v15.i1.113212
Published online Mar 25, 2026. doi: 10.5527/wjn.v15.i1.113212
Figure 3 Forest plot illustrating the chronic kidney disease-in-hospital mortality association in veno-arterial extracorporeal membrane oxygenation cardiogenic shock.
A-C: Subgroup analyses by region; D and E: Subgroup analyses by publication period; F and G: Subgroup analyses by study sample size. Squares: Study odds ratios (effect size); bars: 95% confidence intervals; diamonds: Pooled random-effects estimates. X-axis: Log-scaled; odds ratio > 1 indicates higher mortality with chronic kidney disease. Heterogeneity shown as τ2, χ2, I2, P. Effects are consistently positive across subgroups, larger in Asian cohorts, earlier (≤ 2016) studies, and smaller studies (< 500 patients). CI: Confidence interval.
- Citation: Vadiyala MR, Varghese J, Chilingarashvili G, Ahluwalia V, Sharma S, Raza SMM, Sura H, Pingili A, Desai R. Association of chronic kidney disease with in-hospital mortality of cardiogenic shock patients undergoing veno-arterial extracorporeal membrane oxygenation. World J Nephrol 2026; 15(1): 113212
- URL: https://www.wjgnet.com/2220-6124/full/v15/i1/113212.htm
- DOI: https://dx.doi.org/10.5527/wjn.v15.i1.113212